IP Library Granted Patent US 7,241,856
Granted Patent B2
US 7,241,856 · App. 10/452,269 · Granted Jul 10, 2007

Dental resins, dental composite materials, and method of manufacture thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,241,856
App. No.
10/452,269
Granted
Jul 10, 2007
Kind
B2
Abstract

A low shrinkage, polymerizable oligomer comprises units of the structure: AB  (I) wherein A is an organic radical comprising 1 to about 6 (meth)acrylate groups and 0 to about 5 hydroxy groups; B is an organic radical comprising 1 to about 5 epoxide groups, and wherein A and B are linked through the reaction of an epoxide and a hydroxy group. In one embodiment, a dental restorative material comprises the low shrinkage, polymerizable dental oligomer, a filler system, and a curing system. These polymerizable dental resins may be used for a variety of dental materials, treatments, and restorative functions, including crown and bridge materials, fillings, adhesives, sealants, luting agents or cements, denture base materials, orthodontic materials and sealants, and other dental restorative materials.

Claims (30)

1. A polymerizable dental resin composition comprising:

the reaction product of a hydroxy (meth)acrylate of the formula

wherein m and n are independently 1 to 6; M is a C 1 –C 33 allyl or aryl group that is unsubstituted or substituted with a linear or branched, saturated or unsaturated C 1 –C 12 alkyl, cyclic C 3 –C 7 alkyl, halogen, ester group, ether group, amide group, or aryl group; and R is hydrogen or methyl; and

a multifunctional epoxide of the formula

wherein Y is a divalent C 1 –C 33 alkyl, aryl, heterocycle, or alkaryl group wherein each of the foregoing is unsubstituted or substituted with a linear or branched, saturated or unsaturated C 1 –C 12 alkyl, cyclic C 3 –C 7 alkyl, halogen, ester, ether, amide, or aryl; and q is 0 to about 20; and

a curing system consisting of a free radical cure initiator and a free radical cure accelerator.

2. The polymerizable dental resin composition of claim 1 , wherein the reaction product has a molar ratio of epoxy groups to (meth)acrylate groups of about 1:10 to about 10:1.

3. The polymerizable dental resin composition of claim 1 , wherein the reaction product has a molar ratio of epoxy groups to (meth)acrylate groups of about 1:5 to about 5:1.

4. The polymerizable dental resin composition of claim 1 , wherein the reaction product has a molar ratio of epoxy groups to (meth)acrylate groups of about 1:2 to about 2:1.

5. The polymerizable dental resin composition of claim 1 , wherein M is a divalent C 2 –C 4 alkyl group, or a C 2 –C 10 divalent linear ester group.

6. A polymerizable dental resin composition comprising:

the reaction product of a hydroxy (meth)acrylate of the formula

wherein m and n are independently 1 to 6; M is a C 1 –C 33 alkyl or aryl group that is unsubstituted or substituted with a linear or branched, saturated or unsaturated C 1 –C 12 alkyl, cyclic C 3 –C 7 alkyl, halogen, ester group, ether group, amide group, or aryl group; and

a multifunctional epoxide of the formula

wherein Q is a hydrogen or a halogen; X is an oxygen, sulfur, carbonyl, or a divalent C 1 –C 6 alkyl, alkylether, or aryl group; d is 1 to about 4; and i is 0 to about 6; and

a curing system consisting of a free radical cure initiator and a free radical cure accelerator.

7. The polymerizable dental resin composition of claim 6 , wherein M is a divalent linear C 2 –C 4 alkyl group, or a C 2 –C 10 divalent linear ester group.

8. The polymerizable dental resin composition of claim 1 , wherein the reaction product comprises a compound having the structure:

wherein Y is a divalent C 1 –C 33 alkyl, aryl, heterocyclic, or alkaryl group wherein each of the foregoing is unsubstituted or substituted with a linear or branched, saturated or unsaturated C 1 –C 12 alkyl, ; cyclic C 3 –C 7 alkyl, halogen, ester, ether, amide, or aryl; and q is 0 to about 20;; M is a C 1 –C 33 alkyl or aryl group that is unsubstituted or substituted with a linear or branched, saturated or unsaturated C 1 –C 12 alkyl, cyclic C 3 –C 7 alkyl, halogen, ester group, ether group, amide group, or aryl group; R is hydrogen or methyl; and q is 0 to about 20.

9. The polymerizable dental resin composition of claim 6 , wherein reaction product comprises a compound having the structure:

wherein m is 1 to 3; X is oxygen, sulfur, carbonyl, or a divalent substituted or unsubstituted C 1 –C 6 alkyl or aryl group; i is 0 to about 6; Q is hydrogen, chlorine, bromine or iodine; q is 0 to about 20; M is a C 1 –C 33 alkyl or aryl group that is unsubstituted or substituted with a linear or branched, saturated or unsaturated C 1 –C 12 alkyl, cyclic C 3 –C 7 alkyl, halogen, ester group, ether group, amide group, or aryl group; R is hydrogen or methyl; and d is 2, 3, or 4.

10. The polymerizable dental resin composition of claim 8 , wherein q is 0; M is 1; X is CH 2 or C(CH 3 ) 2 ; i is 1; Q is hydrogen or bromine; and M is a divalent linear C 2 –C 4 alkyl group, or a C 2 –C 10 divalent linear ester group.

11. The polymerizable dental resin composition of claim 9 , wherein q is 0; M is 1; X is CH 2 or C(C 3 ) 2 ; i is 1; Q is hydrogen; and M is —CH 2 CH 2 — or —(C 2 ) 4 CO 2 (CH 2 ) 2 —.

12. A method of manufacturing a polymerizable dental resin comprising reacting, in the presence of a curing system,

a hydroxy (meth)acrylate of the formula

wherein m and n are independently integers from 1 to 6; M is a C 1 –C 33 alkyl or aryl group that is unsubstituted or substituted with a linear or branched, saturated or unsaturated C 1 –C 12 alkyl, cyclic C 3 –C 7 alkyl, halogen, ester group, ether group, amide group, or aryl group; and R is hydrogen or methyl; and

a multifunctional epoxide of the formula

wherein E is an alkyl, alkoxy, alkylether, heterocycle, alkaryl, or aryl group, wherein each of the foregoing groups is unsubstituted or substituted with a linear or branched, saturated or unsaturated C 1 –C 12 alkyl; cyclic C 3 –C 7 alkyl, halogen, ester group, ether group, amide group, or aryl; and x is an integer from 2 to about 6; and

further wherein number of hydroxy groups in (V) is less than one equivalent per equivalents of epoxy groups in (II); and

adding to the reaction product a curing system consisting of a free radical cure initiator and a free radical cure accelerator.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 9, 2021
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: PENTRON CORPORATION
Reel/Frame 055880/0514 →
SECURITY INTEREST Recorded May 8, 2020
From: PENTRON CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052608/0045 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2008
From: COHEN, GORDON S.; THE COHEN FAMILY TRUST PARTNERSHIP
To: PENTRON CLINICAL TECHNOLOGIES, LLC
Reel/Frame 021380/0321 →
AMENDMENT NO. 3 TO MORTGAGE AND SECURITY AGREEMENT DATED MARCH 9, 2005, AMENDED JULY 24, 2006 AND SECOND AMENDMENT DATED JUNE 15, 2007 Recorded Nov 1, 2007
From: PENTRON CLINICAL TECHNOLOGIES, LLC
To: COHEN, GORDON S.; THE COHEN FAMILY TRUST PARTNERSHIP
Reel/Frame 020054/0349 →
AMENDMENT NO. 2 TO MORTGAGE AND SECURITY AGREEMENT DATED MARCH 9, 2005 AND AMENDED JULY 24, 2006 Recorded Oct 25, 2007
From: PENTRON CLINICAL TECHNOLOGIES, LLC
To: COHEN, GORDON S.; THE COHEN FAMILY TRUST PARTNERSHIP
Reel/Frame 020010/0859 →